BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Interleukin-2 receptor γ chain (IL2RG; CD132); interleukin-2 (IL-2); IL-15

October 1, 2015 7:00 AM UTC

In vitro studies identified a peptide inhibitor of IL2RG-binding cytokines that could help treat human T cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM...